SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

--Oppenheimer Adjusts Intercept Pharmaceuticals PT to $20 From $33 Following Q1 Results and Update, Maintains Perform Rating

05/10/2021 07:33

11:22 AM EDT, 05/10/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 16.54, Change: -0.61, Percent Change: -3.56